DT
IOVA icon

Diversified Trust’s Iovance Biotherapeutics IOVA Stock Holding History

Diversified Trust’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,980
Closed -$136K – 940
2024
Q2 		$136K Buy
16,980
+1,469
+9% +$15.7K ﹤0.01% 813
2024
Q1 		$230K Buy
15,511
+1,999
+15% +$23.3K 0.01% 717
2023
Q4 		$110K Buy
13,512
+1,481
+12% +$7.75K ﹤0.01% 831
2023
Q3 		$54.7K Buy
12,031
+178
+2% +$1.16K ﹤0.01% 802
2023
Q2 		$83.4K Buy
11,853
+46
+0.4% +$329 ﹤0.01% 801
2023
Q1 		$72.1K Buy
+11,807
New +$81.5K ﹤0.01% 794

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Diversified Trust's IOVA Position: Q3 2024 in Review

Diversified Trust sold out of Iovance Biotherapeutics (IOVA) in Q3 2024, closing a stake of 16,980 shares — an estimated $136K sold.

Diversified Trust first reported a position in IOVA in Q1 2023 and held it in 6 quarters. The position peaked at $230K in Q1 2024. 286 funds tracked by Wall St. Rank hold IOVA as of Q3 2024.

  • Diversified Trust reported no remaining Iovance Biotherapeutics position as of Q3 2024 after selling out during the quarter.
  • Diversified Trust sold 16,980 Iovance Biotherapeutics shares in Q3 2024, an estimated $136K.
  • Diversified Trust first reported a position in Iovance Biotherapeutics in Q1 2023 and held it in 6 quarters.
  • Diversified Trust's Iovance Biotherapeutics position peaked at $230K in Q1 2024.
  • 286 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2024.

Based on Diversified Trust's 13F filing for Q3 2024, filed 7 Oct 2024.